BioCentury

7:00 AM GMT, Apr 4, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Deals

Cephalon, ChemGenex Pharmaceuticals deal

Cephalon will acquire the 72.4% of cancer company ChemGenex it does not already own for about A$159 million ($163 million) in

Read the full 215 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.